Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Pharmaceutics International Inc
FDA Inspection
•Pharmaceutics International Inc•November 9, 2018

Pharmaceutics International Inc – FDA Inspection, Nov 9, 2018

Record Details

This FDA Inspection record concerns Pharmaceutics International Inc, with an inspection on November 9, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Pharmaceutics International Inc
Inspection Date
November 9, 2018
Product Type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Alice S. Tsao (FDA Associated Person)
  • Alison N. Stieg (FDA Associated Person)
  • David A. Oluwo (FDA Associated Person)
  • Michael Shanks (Issuing Officer)
  • Simone E. Pitts (FDA Associated Person)
View Company Profile

ID · ef1ea56b-657d-4c27-bcb6-2acd36b96c8c

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1071297
FDA center
Human Drugs
Project area
New Drug Evaluation
Outcome
Form 483 issued

FDA Citations

9
  1. 21 CFR 211.142(b)Storage under appropriate conditions
  2. 21 CFR 211.160(b)(3)Drug products-sampling procedures/specifications
  3. 21 CFR 211.160(b)(4)Calibration - at intervals, written program, remedial action
  4. 21 CFR 211.192Extent of discrepancy, failure investigations
  5. 21 CFR 211.192Investigations of discrepancies, failures
  6. 21 CFR 211.22(d)Procedures not in writing, fully followed
  7. 21 CFR 211.42(c)(4)In-Process Material Area
  8. 21 CFR 211.58Buildings not maintained in good state of repair
  9. 21 CFR 211.80(a)Written Procedures Not Followed

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Pharmaceutics International Inc

13
DateClassificationOfficeProject area
December 6, 2024VAIBaltimore District OfficeDrug Quality Assurance
November 14, 2022VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
September 29, 2021VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
July 10, 2020NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
November 16, 2017VAICenter for Drug Evaluation and ResearchGeneric Drug Evaluation
View all 13 other inspections on the company page
Other documents for Pharmaceutics International Inc
  • FDA Inspection 1251950 - 2024-12-06
  • FDA Inspection 1194130 - 2022-11-14
  • FDA Inspection 1155001 - 2021-09-29
  • FDA Inspection 1124614 - 2020-07-10
  • FDA Inspection 1031480 - 2017-11-16

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Pharmaceutics International Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.